Tag: Pancreas
Search News
Our pancreatic cancer research
19th November 2020
November is Pancreatic Cancer Awareness Month and today (19th November) is World Pancreatic Cancer Day. Join us in looking back at some of our pancreatic cancer research from the last year.
Read more
London Pancreas Workshop 2020
30th September 2020
On 11th September 2020, Professors Hemant Kocher and Nick Lemoine hosted the eighth London Pancreas Workshop (LPW) – a forum for state-of-the-art clinical and basic research in pancreatic cancer. In a first for the biennial event, this year’s LPW took place online with pre-recorded speaker presentations and live, interactive Q&A sessions.
Read more
Results from the Phase I STARPAC trial
24th September 2020
A treatment combination involving the addition of a form of vitamin A to the current standard treatment regimen for pancreatic cancer is safe for patients, according to an early phase clinical trial led by Professor Hemant Kocher from Barts Cancer Institute, Queen Mary University of London.
Read more
Metal analysis of urine for pancreatic cancer detection
28th April 2020
Research has revealed that the signature of metal ions present in urine samples is an accurate indicator of pancreatic ductal adenocarcinoma, one of the deadliest types of cancer.
Read more
The TME: Key to controlling cancer cell growth
10th March 2020
The tumour microenvironment: Key to controlling cancer cell growth Research led by Barts Cancer Institute (BCI), Queen Mary University of London, reveals novel insights into the role of the tumour […]
Read more
Foot-and-mouth-disease virus could help target pancreatic cancer
12th February 2020
Researchers at Barts Cancer Institute, Queen Mary University of London, have identified a peptide, or protein fragment, taken from the foot-and-mouth-disease virus that targets another protein, called avβ6 (alpha-v-beta-6). This protein is found at high levels on the surface of the majority of pancreatic cancer cells.
Read more